Provided by Tiger Trade Technology Pte. Ltd.

Vivos Therapeutics

0.1721
+0.00191.12%
Volume:588.83K
Turnover:99.94K
Market Cap:3.46M
PE:-0.09
High:0.1740
Open:0.1647
Low:0.1647
Close:0.1702
52wk High:3.82
52wk Low:0.1575
Shares:20.12M
Float Shares:19.87M
Volume Ratio:1.70
T/O Rate:2.96%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.8267
EPS(LYR):-2.0700
ROE:-8585.26%
ROA:-56.19%
PB:-0.70
PE(LYR):-0.08

Loading ...

Vivos Therapeutics Amends 8-K to Correct Report Date to Sept. 2, 2026

Reuters
·
Yesterday

Vivos Therapeutics Announces Material Debt Reduction

THOMSON REUTERS
·
Sep 08

Vivos Therapeutics Exchanges USD 2.86 Million Streeterville Note Principal for up to 11,445,080 Shares

Reuters
·
Sep 08

Vivos Therapeutics, SPCVA to launch regional sleep testing and treatment center

TIPRANKS
·
Aug 28

Vivos Therapeutics Partners with South Palm Cardiovascular to Launch Florida Sleep Testing, Treatment Center

Reuters
·
Aug 28

Vivos Therapeutics - Expects to Hold 75% Majority Interest in Aim Florida

THOMSON REUTERS
·
Aug 28

Vivos Therapeutics and South Palm Cardiovascular Associates Sign Definitive Agreements to Launch Regional Sleep Testing and Treatment Center

THOMSON REUTERS
·
Aug 28

Vivos Therapeutics - Center Expected to Begin Treating Patients and Generating Revenue in Q1 2027

THOMSON REUTERS
·
Aug 28

Vivos Therapeutics reports new patient referrals at Nevada Sleep & Airway

TIPRANKS
·
Aug 25

Vivos Therapeutics opens sleep testing, treatment facility in Nevada

TIPRANKS
·
Aug 20

Vivos Therapeutics Opens Henderson, Nevada Sleep Testing and Treatment Center, Targets over $10 Million Annual Capacity

Reuters
·
Aug 20

Vivos Therapeutics (VVOS) Q2 2026 Earnings Call: Revenue Up 35%, Liquidity Risks Persist

TradingKey
·
Aug 17

Vivos Therapeutics Inc Reports Results for the Quarter Ended June 30 - Earnings Summary

Reuters
·
Aug 15

Vivos Therapeutics Q2 Revenue Rises 35% on Service Growth

Reuters
·
Aug 15

Vivos Therapeutics Q2 Net Income USD -5.523 Million

Reuters
·
Aug 15

Vivos Therapeutics Q2 Gross Profit USD 2.953 Million

THOMSON REUTERS
·
Aug 15

Vivos Therapeutics Q2 EPS $(0.31) Beats $(0.36) Estimate, Sales $5.153M Miss $5.367M Estimate

Benzinga Earnings
·
Aug 15

Vivos Therapeutics Schedules Release of Second Quarter 2026 Financial Results and Conference Call

GlobeNewswire
·
Aug 14

Vivos Therapeutics Inc Expected to Post a Loss of 39 Cents a Share - Earnings Preview

Reuters
·
Aug 14

Vivos Therapeutics Strengthens IP for Sleep Apnea Devices

TIPRANKS
·
Aug 12